Refractory Large B-cell Lymphoma

Explore clinical trials studying Refractory Large B-cell Lymphoma. Study availability and eligibility vary by location and protocol.

4 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Refractory Large B-cell Lymphoma trial results

Recruiting

NCT04836507

Conditions: ALL (Acute B-Lymphoblastic Leukemia), Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, +15 more
Locations: Samsung Medical Center Seoul, South Korea

The Catholic University of Korea Seoul St. Mary's Hospital Seoul, South Korea

Recruiting

NCT07473167

Conditions: Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, High-grade B-cell Lymphoma (HGBL), +14 more
Locations: Seoul National University Hospital Seoul, South Korea

Recruiting

NCT06811272

Conditions: Refractory Large B-cell Lymphoma, Relapsed Large B-cell Lymphoma
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Newton-Wellesley Hospital Newton, Massachusetts, United States

Completed

NCT04002401

Conditions: Refractory Large B-cell Lymphoma
Locations: Banner MD Anderson Cancer Center Gilbert, Arizona, United States

City of Hope National Medical Center Duarte, California, United States

Stanford Cancer Institute Palo Alto, California, United States

UCLA Hematology/Oncology Santa Monica, California, United States

View all 14 locations